XML 69 R49.htm IDEA: XBRL DOCUMENT v3.24.3
Supplemental information - schedule of redeemable non-controlling interest (Details) - USD ($)
$ in Millions
12 Months Ended
Aug. 31, 2024
Aug. 31, 2023
Aug. 31, 2022
Increase (Decrease) in Temporary Equity [Roll Forward]      
Beginning balance $ 167 $ 1,042 $ 319
Recognition upon acquisition of subsidiary 0 0 2,684
Acquisitions of non-controlling interests 0 0 (2,047)
Net income (loss) attributable to Redeemable non-controlling interests 1 (21) (73)
Redemption price adjustments 6 460 159
Reclassifications to accrued expenses and other liabilities 0 (1,314) 0
Ending balance 174 167 1,042
Conversion of Stock [Line Items]      
Recognition upon acquisition of subsidiary $ 0 $ 0 2,684
VillageMD      
Increase (Decrease) in Temporary Equity [Roll Forward]      
Recognition upon acquisition of subsidiary     1,900
Conversion of Stock [Line Items]      
Recognition upon acquisition of subsidiary     $ 1,900
McKesson Corporation, GEHE Pharma Handel      
Conversion of Stock [Line Items]      
Outstanding equity interest percentage     30.00%